Why Don’t Oncologists Order Molecular Testing?
Many oncologists do not order molecular testing for precision oncology treatment despite the established benefits. An article in JCO Precision [...]
Navigating the FDA Real-Time Oncology Review Process for Sponsors
Started in 2018, the FDA’s “Real-Time Oncology Review (ROTR)” project gives sponsors a head start on the application review [...]
xCures Releases xDECIDE Platform to Personalize Cancer Care Using RWD
Released earlier this month, the xDECIDE platform helps doctors choose the optimal treatment strategy for cancer patients, according to a [...]
Are Mammograms After 75 Worth It?
Uncertainty is building regarding the value of mammograms for breast cancer screening after 75 years of age according to a [...]
[JAMA Article] New Oncology Drugs Command High Price Tags Despite Lack of Improved Survival
In an article published in JAMA Internal Medicine, researchers assessed the costs of 44 new oncology drugs. Surprisingly, they found [...]
New Report Considers Use of Oncology RWE in Successful Submissions to the FDA
In a recent article published in Clinical Cancer Research, investigators analyzed successful submissions of oncology drugs to the Food and [...]
Takeda Partners With Point32Health to Offer Value-Based Oncology Program in US
Takeda has partnered with Point32Health in a new value-based oncology program. Alunbrig, used in non-small cell lung cancer, is the [...]
Prospective Oncology Real-World Data Capture
Scientist on November 2, 2021 in Tech Snapshot Tech Snapshot® captures today’s cutting-edge tools and technologies that will help drive drug [...]
Merck’s Keytruda Expected to Hit $17 Billion Yearly Revenue
Merck’s Keytruda continues to generate billion-dollar sales. The oncology drug reached $4.5 billion of sales in the third quarter, making [...]
EQRx Partners With Two Payers to Reduce Drug Costs, Seeks Chinese Approval of Low Cost Oncology Drugs
EQRx has formed partnerships with two healthcare insurance companies to reach its ambitious goal of reducing drug costs. The company [...]
xCures Seeks to Improve Patient Outcomes Using Targeted Oncology RWD
xCures aims to improve the outcomes of patients with cancer using real world data (RWD) tools. Quickly identifying relevant patient [...]
[Podcast] Merck Marketing Expert Discusses AI in Oncology Care
In a recent episode of Life Science Marketing Radio, Chris Conner interviewed Hemal Somaiya, Global Brand Lead for Oncology at [...]
The Health Design Podcast Interviews xCures CEO
In a recent installment of the Health Design Podcast, Moyez Jiwa interviewed xCures CEO Mika Newton. Newton’s many previous roles [...]
Why Did Medicare Squander $600 Million on Efficacy-Free Cancer Drugs?
According to a new JAMA report, Medicare spent almost $600 million in three years on drugs used in oncology treatments. [...]
Syapse Announces RWD Partnership with Merck to Accelerate Oncology Research and Improve Patient Outcomes
Real world evidence (RWE) leader Syapse has announced a partnership with Merck. Together, the companies will utilize real world data [...]
On-Demand Webinar on Unmet Need in Oncology Healthcare
BioPlus Specialty Pharmacy is offering an on-demand webinar featuring EVP and Oncology Practice Head at Cello Health BioConsulting Jeff Bockman, Ph.D. [...]
Massive Bio Announces Partnership With Patient-Centered Group Self Care Catalysts and Veterans Prostate Cancer Awareness Non-Profit to Improve Clinical Trial Diversity and Oncology RWE
Massive Bio will partner with non-profit group Veterans Prostate Cancer Awareness (VPCa) and patient-centered organization Self-Care Catalysts to promote enrollment [...]
JMCP Article Details Payer Perceptions of Oncology RWD During Drug Launches
In a recent article published in the Journal of Managed Care and Specialty Pharmacy (JMCP), the authors discuss the use [...]
Aduhelm Approval Prompts Discussions on Reforming the FDA’s Accelerated Approval Pathway
The Food and Drug Administration (FDA)’s contentious approval of Biogen’s Aduhelm has prompted discussions on how the accelerated approval process [...]
xCures VP Discusses Leveraging RWD Registries to Provide Personalized Care to Oncology Patients
Vice President of Research Partnerships at xCures Max Goldstein discusses using real world data (RWD) to better understand which patients [...]
Researchers Evaluate Oncology Treatment Costs at the National Cancer Institute and Community Hospitals
Researchers evaluated costs associated with cancer treatment in community hospitals and at the National Cancer Insitute (NCI), noting variation in [...]
Register Today for IQVIA’s Tuesday Webinar on Surrogate Endpoints in Oncology Clinical Trials
The IQVIA Institute for Human Data Science will host a webinar at 10:00 AM EDT on Tuesday, August 17th on [...]
Upcoming ISPOR Webinar on Successfully Incorporating External Controls Into Oncology RWE Studies
The International Society for Pharmacoeconomics and Outcomes (ISPOR) will host a webinar on August 12th at 2:00 PM EDT on successfully [...]
JMCP Article Discusses Payer Viewpoints Regarding RWE, Notes Widespread Use of Claims Data
An article published in the Journal Of Managed Care and Specialty Pharmacy discusses how real world evidence (RWE) can inform [...]
Study Highlights Use of RWD and Data Analytics to Identify High-Risk Prostate Cancer Patients
Researchers at the University of Michigan used real world data (RWD) and data analytics to determine which prostate cancer patients [...]
